Show simple item record

dc.contributor.authorDamjanov, Dimitrije
dc.contributor.authorStojčević Maletić, Jelena
dc.contributor.authorPetrović, Tamaš
dc.contributor.authorSavić, Željka
dc.contributor.authorKnežević, Milica
dc.contributor.authorGajdov, Vladimir
dc.contributor.authorRužić, Maja
dc.date.accessioned2026-07-13T11:30:14Z
dc.date.available2026-07-13T11:30:14Z
dc.date.issued2026-05
dc.identifier.citationDamjanov, D., Maletić, J.S., Petrović, T. et al. Hepatitis E virus seroprevalence and infection status among patients with inflammatory bowel disease undergoing advanced therapy: a prospective single-center observational study. BMC Gastroenterol 26, 415 (2026). https://doi.org/10.1186/s12876-026-04907-1en_US
dc.identifier.issn1471-230x
dc.identifier.urihttps://repo.niv.ns.ac.rs/xmlui/handle/123456789/1140
dc.language.isoenen_US
dc.publisherSpringer Nature Linken_US
dc.sourceBMC Gastroenterologyen_US
dc.subjectHepatitis Een_US
dc.subjectInflammatory bowel diseaseen_US
dc.subjectBiologic therapyen_US
dc.titleHepatitis E virus seroprevalence and infection status among patients with inflammatory bowel disease undergoing advanced therapy: a prospective single-center observational studyen_US
dc.typeArticleen_US
dc.identifier.doi10.1186/s12876-026-04907-1
dc.citation.volume26en_US
dc.citation.spage415en_US
dc.citation.rankM22en_US
dc.type.versionpublisheden_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record